Recent Quotes View Full List My Watchlist Create Watchlist Indicators DJI Nasdaq Composite SPX Gold Crude Oil Hydroworld Market Index Markets Stocks ETFs Tools Overview News Currencies International Treasuries (OP: MDXXF ) 0.0803 +0.0051 (+6.78%) Streaming Delayed Price Updated: 9:30 AM EDT, Jul 31, 2024 Add to My Watchlist Quote Overview Detailed Quote Charting Historical Prices News All News News Headlines Press Releases Research Quarterly Reports Insider Filings Other Filings All News about MDXXF Canadian Biotech Duo Hits Psilocybin Extraction Milestone For API Development At Scale May 29, 2024 Red Light Holland and PharmAla achieve psilocybin extraction milestone, advancing API development for scalable medical products. Read now! Via Benzinga Psychedelics Headlines: Dementia Prevention, Psychological Flexibility, Ancient Romans' Trips And More April 17, 2024 Via Benzinga Cortexa Commences Manufacturing GMP LaNeo™ MDMA in Australia April 05, 2024 Novel Composition of MDMA Enantiomers leading to next-generation MDMA possibilities From PharmAla Biotech Via GlobeNewswire Psychedelics Headlines: A Form Of Life, Treating Chronic Pain, Microdosing And More March 30, 2024 Via Benzinga Psyched: 5-MeO-DMT For Depression, Utah Hospitals Providing Therapy, Elon Musk And Meta's Influence March 29, 2024 Via Benzinga PharmAla's Novel MDMA Mixture Awarded US Patent, Enabling IP Protection And Further Development March 27, 2024 Via Benzinga Topics Intellectual Property Exposures Intellectual Property Patent Allowance Granted for ALA-002 Composition by US Patent and Trademark Office March 27, 2024 Novel Composition of MDMA Enantiomers leading to next-generation MDMA possibilities From PharmAla Biotech Via GlobeNewswire Two Top Biotechs Forge MDMA Supply Deals For Clinical Research March 26, 2024 Via Benzinga Patent Allowance Granted for P-1 Molecule by US Patent and Trademark Office March 20, 2024 Novel MDMA-Like Drug Could Be Used for Numerous Neurological and Psychiatric Indications From PharmAla Biotech Via GlobeNewswire Cortexa Leads the World in First Supply of Psilocybin Under the TGA’s Authorized Prescriber Scheme March 18, 2024 PharmAla now first company to supply both MDMA and Psilocybin into the Australian Market From PharmAla Biotech Via GlobeNewswire Truffles To Market: Red Light Holland Wants To Develop Psilocybin API At Scale March 11, 2024 Via Benzinga Psychedelics Headlines: Trauma-Informed Care, Valentine's Day & MDMA, Academics On Drugs And More February 15, 2024 Via Benzinga Data & News supplied by www.cloudquote.io Stock quotes supplied by Barchart Quotes delayed at least 20 minutes. By accessing this page, you agree to the following Privacy Policy and Terms and Conditions.